Janus kinase versus TNF inhibitors: where we stand today in rheumatoid arthritis
- 4 May 2022
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Clinical Immunology
- Vol. 18 (5) , 485-493
Abstract
In recent decades, Rheumatoid arthritis (RA) treatment landscape has evolved with the induction of new biological and targeted therapies that provide significant therapeutic benefits in patients wi...Keywords
This publication has 92 references indexed in Scilit:
- ‘Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA‘Annals of the Rheumatic Diseases, 2013
- Outcomes of switching anti-TNF drugs in rheumatoid arthritis—a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN)Clinical Rheumatology, 2011
- Use of Biologics in Rheumatoid Arthritis: Current and Emerging Paradigms of CareClinical Therapeutics, 2011
- Transmembrane TNF- : structure, function and interaction with anti-TNF agentsRheumatology, 2010
- Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registryArthritis & Rheumatism, 2009
- Efficacy and safety of certolizumab pegol monotherapy every 4 weeks in patients with rheumatoid arthritis failing previous disease-modifying antirheumatic therapy: the FAST4WARD studyAnnals of the Rheumatic Diseases, 2009
- Golimumab, a human antibody to tumour necrosis factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD StudyAnnals of the Rheumatic Diseases, 2009
- Anti-TNF immunotherapy and tuberculosis reactivation: another mechanism revealedJournal of Clinical Investigation, 2009
- Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims dataCurrent Medical Research and Opinion, 2007
- Anti-TNF-α therapies: the next generationNature Reviews Drug Discovery, 2003